Education
About Us
Working with TipRanks
Follow Us
Bonus Biogroup Ltd. (IL:BONS)
:BONS
Total Valuation
Bonus Biogroup has a market cap or net worth of $246.43M. The enterprise value is 87.51M.
Market Cap$246.43M
Enterprise Value87.51M
Share Statistics
Bonus Biogroup has 1,167,925,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,167,925,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bonus Biogroup’s return on equity (ROE) is -0.97 and return on invested capital (ROIC) is -73.62%.
Return on Equity (ROE)-0.97
Return on Assets (ROA)-0.64
Return on Invested Capital (ROIC)-73.62%
Return on Capital Employed (ROCE)-0.76
Revenue Per Employee0.00
Profits Per Employee-582.22K
Employee Count49
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Bonus Biogroup is -6.88. Bonus Biogroup’s PEG ratio is 0.05.
PE Ratio-6.88
PS Ratio0.00
PB Ratio2.29
Price to Fair Value6.70
Price to FCF-3.67
Price to Operating Cash Flow-4.48
PEG Ratio0.05
Income Statement
In the last 12 months, Bonus Biogroup had revenue of 0.00 and earned -28.53M in profits. Earnings per share was -0.02.
Revenue0.00
Gross Profit0.00
Operating Income-29.79M
Pretax Income-28.53M
Net Income-28.53M
EBITDA-28.14M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -21.37M and capital expenditures -342.00K, giving a free cash flow of -21.72M billion.
Operating Cash Flow-21.37M
Free Cash Flow-21.72M
Free Cash Flow per Share-0.02
Dividends & Yields
Bonus Biogroup pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.97
52-Week Price Change31.41%
50-Day Moving Average20.35
200-Day Moving Average15.87
Relative Strength Index (RSI)46.60
Average Volume (3m)2.40M
Important Dates
Bonus Biogroup upcoming earnings date is Nov 30, 2021, TBA (Confirmed).
Last Earnings DateAug 29, 2021
Next Earnings DateNov 30, 2021
Ex-Dividend Date―
Financial Position
Bonus Biogroup as a current ratio of 4.47, with Debt / Equity ratio of 21.20%
Current Ratio4.47
Quick Ratio4.47
Debt to Market Cap0.00
Net Debt to EBITDA0.06
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Bonus Biogroup has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bonus Biogroup EV to EBITDA ratio is -6.91, with an EV/FCF ratio of -7.14.
EV to Sales0.00
EV to EBITDA-6.91
EV to Free Cash Flow-7.14
EV to Operating Cash Flow-7.37
Balance Sheet
Bonus Biogroup has $6.86M in cash and marketable securities with 10.19M in debt, giving a net cash position of $3.33M billion.
Cash & Marketable Securities$6.86M
Total Debt10.19M
Net Cash$3.33M
Net Cash Per Share<$0.01
Tangible Book Value Per Share$0.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Bonus Biogroup is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―